Image Credit: Stony Brook University
Stony Brook, New York — Dr. Joe Verghese, an expert in neurology and geriatrics, has been appointed as the new chair of the Department of Neurology at Stony Brook University’s Renaissance School of Medicine.
With over three decades of experience in studying and treating aging-related neurological conditions, his new role signals a significant step in expanding the university’s research and clinical care for neurodegenerative diseases.
Dr. Verghese, originally from Kerala, India, brings a wealth of experience, particularly in understanding gait disorders and dementia among older adults.
His groundbreaking research has established critical links between mobility and cognitive decline, making him a key figure in the field of cognitive aging.
Prior to his appointment at Stony Brook, he held leadership positions at the Albert Einstein College of Medicine and Montefiore Medical Center, where he developed clinical programs to enhance patient care for neurological disorders in old age.
Welcoming Dr. Verghese, Peter Igarashi, Dean of the Renaissance School of Medicine, noted, “We are really looking forward to having Dr. Verghese as our new chair. His track record of clinical excellence and innovative research will surely benefit us greatly as we continue to grow our neurology services and research efforts.”
Stony Brook’s neurology department, already recognized for its expertise in stroke, epilepsy, and movement disorders, aims to leverage Dr. Verghese’s expertise to expand its focus on neurodegenerative diseases like Alzheimer’s and Parkinson’s.
These conditions are projected to impact millions of Americans as the population ages. Dr. Verghese’s appointment comes at a pivotal time, positioning the department to lead advancements in neurological research and patient care.
“I feel privileged to be joining Stony Brook University at such an exciting time in the history of neurology,” Dr. Verghese said. “I look forward to working with the talented team here to advance our understanding of neurological diseases and improve care for patients.”